Ian, who helped devise the PROTECT ME acronym which is now used worldwide to champion the cause of responsible antimicrobial use, said: "Antimicrobial resistance is one of the greatest threats of our time and it affects all sectors of the veterinary profession.
"While there will always remain a need for the use of antimicrobials for the treatment of bacterial infections, it is the duty of every one of us to continue our good work to protect their usage to ensure they remain effective for the future."
PROTECT ME stands for Prescribe only when necessary, Reduce prophylaxis, Offer other options, Treat effectively, Employ narrow spectrum, Cure appropriately, Tailor your practice policy. Monitor, Educate others.
Ian added: "I discussed the issue of restricted prescribing with my Doctor when he was treating my injury back in 2011
"Discussion on the Small Animal Medicine Society (SAMSOC) forum followed and then we developed a working group.
"I came up the name PROTECT when I was in the shower one day experimenting with acronyms on the shower cubicle wall!
"Collaboration with BSAVA enabled the scheme to launch in 2012 and then BEVA adapted the scheme and added the ME.”
PROTECT ME is now used for BSAVA and BEVA’s antimicrobial resources and campaigns and has also been taken up in New Zealand and been translated into French.
Rachael McGregor, Clinical Director at Calder Vets in Yorkshire asked Ian for help in developing antimicrobial stewardship guidelines for the practice last year. She said: “Ian helped us to set up prescribing guidelines using a traffic light system, supported a programme of CPD and supplied prescribing posters. This has made a significant difference to prescribing behaviour across the practice and over the past two months we haven’t prescribed a single critically important antibiotic.”
Davies has produced a range of resources for vets and for pet owners including an explanatory poster and a webinar series. For further information visit: https://vetspecialists.co.uk/insights/webinars/antimicrobial-webinars/
Researchers at the Royal Veterinary College have officially launched a new Feline Diabetic Remission Clinic in the Queen Mother Hospital for Animals in Hertfordshire, to investigate the optimum methods to achieve good control, and ultimately diabetic remission, in diabetic cats.
Led by Dr Stijn Niessen, the team at the new clinic will offer diabetic cats optimum management, while at the same time gathering information to enhance current scientific understanding of the best treatment for diabetic cats.
Feline diabetes mellitus is a costly, chronic disease which can significantly decrease the quality of life of both cat owners and their pets. However, a proportion of diabetic cats can achieve diabetic remission and no longer require insulin therapy, which is increasingly considered the ultimate goal in treating diabetic cats. According to the RVC, early evidence suggests that good, early blood glucose control increases remission rates in diabetic cats. However, there is little evidence about which treatment protocol offers the best blood glucose control and chance of remission.Stijn said: "Our mission is to investigate the best method of achieving good blood glucose control, and diabetic remission, in diabetic cats. The clinic also aims to identify predictors of diabetic remission, which will help veterinarians advise their clients on the chance of their cat achieving diabetic remission in the future."
He added: "Interestingly, most cats seem to suffer from a similar type of diabetes as most humans. We always suspected cats to be extremely wise, but isn't it interesting to know that they also might hold the answer to many questions we have about the human disease!"
The clinic is currently recruiting cats that have had diabetes for less than 4 months' duration for a clinical trial, examining the effect of new insulins on blood glucose control and remission rate.
Enrolled cats will qualify for full underlying disease assessment at the referral hospital, several re-examination appointments, 12 months of prescription diabetic food, and 6 months of insulin therapy - all at no cost to owners.
For more information on the trial or the work of the clinic, contact Feline Diabetic Remission Clinic: telephone: 01707 666 605 or email: fdrc@rvc.ac.uk
Boehringer Ingelheim Vetmedica, manufacturer of the equine pergolide Prascend, has joined forces with the British Horse Society, Redwings Horse Sanctuary and World Horse Welfare to launch the 'Talk About Cushing's (TAC)' campaign.
The initiative, which will take place throughout September and October 2011, is aimed at raising awareness of Cushing's Disease and its clinical signs, perhaps the most familiar of which is hirsutism (abnormal hair growth, or delayed shedding). Horse owners can download a £15 money-off voucher from http://www.talkaboutcushings.co.uk/ throughout the TAC initiative, which can be redeemed through their veterinary practice against blood test costs.
Boehringer says Equine Cushing's Disease, also known as Pituitary Pars Intermedia Dysfunction (PPID), is the most common endocrine disorder in older horses and ponies1 ,and that some estimates suggest over 15% of horses and ponies over 15 years of age are affected2.
Unfortunately, the initial stages of Cushing's Disease are often difficult to detect, delaying the maximum benefit of early diagnosis and intervention. Blood testing is increasingly used to detect the disease and confirm diagnosis, however many horses with clinical signs, including recurrent laminitis, still go undiagnosed.
Craig Beck, vet and equine sales and marketing manager at Boehringer Ingelheim Vetmedica said: "More than 80% of horses suffering from laminitis may have an underlying endocrine disorder, such as Cushing's Disease3.
"The TAC campaign will raise awareness of Cushing's Disease amongst both veterinary professionals and owners. It should make it easier for vets to go ahead with endocrine testing in horses and ponies with recurrent laminitis, diagnosing and treating earlier in the course of the disease."
Lee Hackett, head of welfare at the BHS, added: "Cushing's Disease is relatively common in horses yet in our experience it frequently goes undiagnosed and untreated. This is why we are fully behind the 'Talk About Cushing's' campaign - anything that raises awareness and understanding of this disease has to be of benefit to equine welfare."
Redwings' head of veterinary services Nicky Jarvis said: "At Redwings we have many horses over the age of 15, all living very happy and healthy lives. 'Old age' is not in itself a disease so when a geriatric horse loses condition or appears unwell there is always an underlying cause. If a horse continually succumbs to laminitis or loses weight, Cushing's Disease could be one explanation. However, with early diagnosis, good management and the correct treatment a horse with Cushing's can live comfortably for many years."
"Early diagnosis of Cushing's Disease can be of great benefit, other conditions such as laminitis are often associated with it and it is important that clinical signs are recognised and treated appropriately. World Horse Welfare supports the 'Talk About Cushing's' campaign as it will help people to recognise the signs and take the right action to prevent horses from suffering," concludes Tony Tyler, deputy chief executive, World Horse Welfare.
Backed by an advertising and PR campaign in the equine consumer media, Boehringer Ingelheim Vetmedica has produced a marketing pack for veterinary practices to use in the run up to, and during TAC. This includes leaflets, invoice stickers, a veterinary practice toolkit featuring an owner evening presentation, editorial copy for newsletters and websites and images to support the campaign.
For further information on TAC or Prascend, the first licensed product for the treatment of Cushing's Disease, please visit http://www.talkaboutcushings.co.uk/, contact your Boehringer Ingelheim Vetmedica territory manager or call 01344 746959.
References
1. Donaldson et al. “Evaluation of suspected pituitary pars intermedia dysfunction in horses with laminitis”. JAVMA, Vol 224, No. 7, April 1, 20042. McGowan. “Diagnostic and Management Protocols for Equine Cushings Syndrome” In Practice, November/December 20033. McGowan. “Epidemiology and Clinical Perspectives of Endocrinopathic Laminitis”, BEVA Congress 2009
Dentistry Specialists: Andrew Perry, Jose C. Almansa Ruiz, Rachel Perry, and Bob Partridge, together with veterinary dentists Dr Matthew Oxford FRCVS, Evelyn Barbour-Hill and Susan Thorne join the team of Small Animal Medicine Specialists who are also on hand to answer questions posted by GP vets on VetSurgeon.org
All questions asked on VetSurgeon.org are added to a searchable knowledge base for the benefit of everyone in the profession. So anyone who asks a question is not just doing it for their own benefit, but for everyone.
Questions can be case-related, or broader questions asking what the team thinks about a drug, technique or piece of research.
Anyone who subscribes to the VetSurgeon Digest of questions here, and posts a dentistry question here before 30th September 2023 will have their name put in the hat for a bottle of Moet champagne.
VetSurgeon.org Editor Arlo Guthrie said: “One other thing. Do share this news story with your colleagues in general practice. For them to be able to tap into the minds of some of the leading lights in both dentistry and medicine is a really amazing resource, especially for more recent grads."
ECVS and RCVS Small Animal Surgery Specialist Vassilis Chantziaras (pictured) will lead the event, where attendees will be able to deepen their understanding of both common and unusual orthopaedic conditions.
The session will be split into a case review where delegates will discuss the presented cases in small groups, followed by a case presentation and group discussion led by Vassilis.
Andrew Kent, Clinical Director at Blaise, said: “We’re privileged to have such an incredible team here at Blaise and it’s important that they are able to share their expertise and knowledge for others to learn from and grow their own careers.
"We have many more learning and development opportunities and events in the pipeline and look forward to welcoming our veterinary industry colleagues to our hospital.”
www.ivcevidensiareferrals.com/events-and-cpd
The app allows practices to submit results along with cytology and histopathology results in order to help train the AI algorithm and improve its accuracy from an original sensitivity of 85% and negative predictive value of 97%.
Liron Levy-Hirsch, Managing Director of HT Vista, said: “The HT app has provided us with over 700 additional validated scans to analyse this year alone.
"The validation process is well controlled, whereby we use the lab results to tag the scans as benign or malignant and let the algorithm know if it was correct or not.
"The more we train the algorithm the more accurate it becomes, and it is extremely exciting to see the sensitivity increase to 90% and the NPV to 98%.”
HT Vista says the app was developed to meet demand from clinics.
Liron said: "By having a portal to upload lab results alongside the device’s results not only do we further improve the device, but we also increase confidence among our vets and nurses that the device is a reliable tool.
https://ht-vista.uk
'Managing Veterinary Medicines' teaches safe and responsible use of veterinary medicines and medicine regulations.
RCVS Knowledge says it will also show you how to put systems in place that will reduce errors, improve patient outcomes and improve practice systems.
It's worth six hours of CPD.
The course has been produced in collaboration between RCVS Knowledge and the Veterinary Medicines Directorate (VMD), and includes a range of webinars, podcasts and articles.
Executive Director at RCVS Knowledge, Chris Gush said: “In England alone, more than 1,700 people die yearly because of medication errors.
"While we don't know the true figures in veterinary medicine, we do know that 30% of errors reported to the VDS's VetSafe system are due to medication errors.
“That's why we think it's vital to have good robust systems in place in the practice dispensary and to use QI tools like guidelines, protocols, and checklists.
CEO of the VMD, Abi Seager said: “Managing Veterinary Medicines will help teams comply with legislation as well as keep patients, team members and clients safe when prescribing and dispensing medicine.”
The course will also prepare practices for a VMD inspection or an RCVS Practice Standards Scheme assessment.
https://learn.rcvsknowledge.org
Vygon Vet has launched two new 'procedure packs' containing disposable essentials for unblocking a tomcat or performing a spay or minor surgery.
The KatKath Urinary Catheter Insertion Pack contains a catheter, a drape towel, polypropylene suture, lubricating gel, a Luer-slip syringe and a clear tray. The complete set costs £10.99.
Vygon Vet General Manager Chris Kenyon, said: "Not only does our KatKath pack ensure everything that's needed is in one place and sterile, it can also save vets up to 50% compared with prices if they buy similar products separately. It's a win-win situation."
The Spay Tray and Minor Operations Set (pictured right) includes a selection of forceps, a Mayo Hagar needle holder, a scalpel, a pair of dissecting scissors, a hand towel, drapes, a tray and five radiopaque swabs.
Chris said: "Our Spay Tray and Minor Ops Sets are produced to the highest standards using top quality materials. Having the required items in one pack eradicates the need to go through the expensive process of washing, re-packing and re-sterilisation, and from an admin point of view invoicing is easy with one single code covering all the different pack parts."
The Spay Tray and Minor Ops Sets are available for an introductory price of £12.50 for a limited period.
In the blurb, Vygon Vet says the benefits of its procedure packs include:
The company is also offering a retrieval service through which the instruments from up to ten packs can be disposed for £14.50.
For more information, visit www.vygonvet.co.uk, telephone: 01793 748900 or visit Vygon Vet at the forthcoming BSAVA Scottish Congress (29-31st August at the Edinburgh Conference Centre).
The International Society of Feline Medicine (ISFM) has published 'Consensus Guidelines on the Long-term use of NSAIDs in cats' in the July 2010 edition of the Journal of Feline Medicine and Surgery.
The society says it has developed the guidelines in order to try and address the major welfare issue of cats suffering unremitting and untreated chronic pain. Until recently, NSAIDs had only been licensed for short-term use in cats, but with changing licensing indications and recommendations, they are now also increasingly used for long-term treatment of cats, for example in the management of osteoarthritis.
However, in most cases where long-term use of pain relief in cats is required, there are concomitant problems with other diseases or other drugs that are being given. According to the ISFM, one of the most common concerns is whether NSAIDs can be used to treat arthritis in older cats with kidney disease. The society says that because of concerns like these, and the potential for adverse effects, cats often receive no treatment at all, and their quality of life can be severely compromised.
For this reason, the ISFM set up an international expert panel to develop practical and rational guidelines on the long-term use of NSAIDs in cats. The aim was to provide guidelines that would empower clinicians, enabling them to make sensible and rational choices, and ensure much-needed therapy is not needlessly withheld from patients.
The panel was made up of Andrew Sparkes, Duncan Lascelles, Richard Malik, Sheilah Robertson, Margie Scherk, Polly Taylor, Llibertat Real Sampietro and Reidun Heiene.
Along with the veterinary information in the guidelines, the panel also developed a brief client-facing leaflet that can be given to owners when NSAIDs are prescribed for their cats - this leaflet provides simple, clear advice on why NSAIDs are used, why they are important, but also what simple precautions avoid adverse effects, with further advice on when to seek veterinary advice to reinforce the safety message.
Both of these publications are available to download from the website www.isfm.net/toolbox
Simon Dennis, lecturer in cardiology and Rob Goggs, staff clinician in emergency and critical care, both from the Royal Veterinary College have completed a gruelling four day charity bicycle ride from London to Paris.
The bike ride was in aid of Action Medical Research (AMR), a medical research charity dedicated to helping babies and children through tackling premature birth and treating sick and vulnerable babies; helping children affected by disability, disabling conditions and infections; and targeting rare diseases that severely affect many forgotten children.
The cycling duo is aiming to raise £3,000 for this cause and have already raised about £2,400.
The race ended with 600 other cyclists riding in unison through the centre of Paris, with the watching crowd cheering the cyclists on from the streets and cars.
Simon Dennis said: "Both Rob and I are extremely pleased to have completed the cycle ride and raise money for such a worthy cause. It was a tough four days, but definitely worth it in the end, as it was an incredible once in a lifetime experience for us both."
"We would like to thank everyone for their donations, but particularly CEVA Animal Health and Boehringer Ingelheim, who were both really generous sponsors to the charity."
If you would like to donate money to this cause please visit http://www.action.org.uk/sponsor/sgdennis
Dechra Pharmaceuticals PLC has announced that it has acquired the entire issued share capital of Genitrix Limited ("Genitrix") from its owner managers for an initial cash consideration of £5.4 million, with a further £0.8 million being payable upon achievement of specific milestones.
Dechra says the acquisition of Genitrix is consistent with its strategy to grow its international veterinary pharmaceutical business. In the year ended 31 March 2010, Genitrix achieved revenues of £2.4 million.
Ian Page, Chief Executive of Dechra, said: "Genitrix range of equine and companion animal products enhances and complements our UK product portfolio. Furthermore the recently approved canine epilepsy product, Libromide, provides future growth opportunities through potential mutual recognition in Europe. The acquisition is expected to be earnings enhancing in the first full year following ownership."
The trial is the result of a six-week consultation held by the College in June 2016, asking for the profession’s views on a proposed new system of CPD - one that concentrates less on hours logged and more on interactive, reflective learning and measuring the impact that CPD has on the individual’s practice and patient health outcomes.
The College says that while an overall majority of the 3,357 people who responded to the College’s consultation agreed with the proposed changes to the CPD requirement, certain elements received less support than others. The lowest amount of support was received for the ‘reflection’ component with 35% of respondents disagreeing with it.
The RCVS Education Committee and VN Council therefore agreed that a pilot of a new outcomes-based approach should be held during 2017 before making a recommendation to RCVS Council. The RCVS Council approved this proposal at its meeting on 10 November 2016, after which 117 volunteers were recruited, 60 of whom were able to attend the training days.
A veterinary surgeon who signed up for the pilot and works in veterinary industry, Gina Dungworth, said: "I really appreciate the acknowledgement of non-clinical CPD practices, and while I was originally sceptical of the proposed system the pilot day has so far been clear and helpful."
A veterinary nurse volunteer, Lindsey Raven Emrich, said: "CPD is such a varied part of a veterinary professional’s career, and it very much depends on the person how easy it is to do. I find myself doing a lot of reflection as a natural part of reading articles, and I’m hoping this new system will expand that way of thinking into other areas of CPD."
The volunteers will now pilot the new proposed system and report to Education Committee, VN Council and RCVS Council.
The publication of the guide follows a study of vet professionals published in the Journal of Feline Medicine and Surgery which revealed that the main barriers to blood pressure measurement are a lack of time (72.8%) and situational hypertension (92%)1.
Vet professionals also thought the main barrier for owners was cost (80%) whilst the least problematic aspect is the longer consultation needed to accommodate a blood pressure measurement (48.8%).
The guide has been written to address these concerns and empower vet nurses to run nurse-led clinics for older pets.
Written by RVN, Beth Kirwan, the guide provides information on the benefits of vet nurse-led senior pet clinics, which can either be free or paid, together with hints and tips on how to get started and promotion.
The guide also covers the importance of a senior health-check questionnaire, tips on preparing and setting up a clinic, a 10-point health check providing guidance on what should be covered and information on additional senior pet tests that can be carried out, such as blood pressure checks for senior cats aged seven years or older to help identify feline hypertension.
Beth said: "I was really excited to be asked by Ceva to create this resource for veterinary nurses and grateful for the opportunity to share my experiences and knowledge.
"I have been a nurse for over 22 years, and I am passionate about making our nurses feel valued in practice.
"Nurse clinics are a really good way to do this, but I feel that setting up a senior nurse clinic service in a practice creates so much value in many ways and for every member of the practice, from the receptionists to the vets.
"Our RVNs are the stars of the show with senior nurse clinics; they bring so much experience, care and compassion and are a great reflection of our practice values.
"They often have the time that the vets don't have and will go home knowing they made a difference to a pet and an owner, or a family.
"Veterinary nurses can help identify disease early, support the owners with home adaptations or new medicine regimes.
"They can also educate the clients in senior and super senior care as our pets are living longer and provide quality of life and end of life support.
"The benefits are huge; as well as a financial benefit support like this will bond clients to a practice for life.
"We are all businesses, but we need to be caring businesses.
"I hope the guide provides inspiration to many nurses and empowers them to set up a new service or helps them to improve their current one."
Dr Sarah Caney, RCVS recognised Specialist in Feline Medicine who led the study said: “Our recent survey had more VN participants than vets, showing just how enthusiastic and engaged nurses are when it comes to assessing blood pressure in cats.
"Owners very much appreciate nurse clinics and I’m delighted to hear that there is a new senior pet clinics guide to support nurses in setting up and running successful clinics.”
https://easethepressure.co.uk/feline-senior-health-clinics
Reference
Containing 3% m/v Chlorhexidine, Pyoderm is designed to support the natural microbial balance of the skin whilst delivering gentle yet effective cleansing.
Along with the rest of Virbac's range of dermatological and everyday care shampoos, Pyoderm is presented in 250ml eco-friendly bottles which are made from 100% recycled plastic and recyclable packaging.
The shampoos themselves are also biodegradable.
https://uk.virbac.com/
The free app is designed to help to track changes and improvements in a dog’s health during treatment.
The app uses questionnaires to monitor clinical signs and quality of life and includes reminders for when checkups with routine blood tests should be carried out, which Dechra says are recommended at 10 days, 4 weeks, 12 weeks and every 3 months thereafter.
The app also sends pet owners daily reminders to administer medication to their dog.
Sarah Musgrave, companion animal brand manager at Dechra, said: “Continuous and consistent monitoring is key to finding the right Vetoryl dose for a dog with Cushing’s and restoring its health.
"The new Cushing’s syndrome treatment and monitoring app is a useful tool to help owners quickly and easily record and track any medical and lifestyle changes in dogs being treated with Vetoryl, which can then be shared with their vet during check-ups.”
To download the app, search for 'Cushing's monitoring' on either Apple's App Store or the Google Play Store.
There are a number of reasons why you may wish to raise your professional profile online.
For example, referral practitioners, it’ll help raise your profile as you build your client base.
Likewise, it will make it easier for clients to find general practitioners who’ve moved job.
Practice owners and managers might also like to encourage staff to create professional profiles with a link to the practice website, which will help push it up the search engine results.
Finally, any supplier of products or services to the profession can complete a profile about their business.
Activating your new professional profile is simple.
First, login and visit www.vetsurgeon.org/user/settings and enter your practice or business website, to appear on your profile (NB. You MUST include the http:// or https:// part of the address).
Then visit and complete your profile page from the ‘View/Edit my profile' link in the main site navigation.
Then press the link at the top right which says ‘Make Profile Public’ (it’s reversible at any time, if you change your mind).
A LIMITED amount of information from your profile will then be made visible to search engines and publicly on the site (ie without logging in).
You will need to allow a few days before your entry starts to appear in search engines like Google.
Importantly, your telephone number and address are NOT revealed, and nor is your extended career history (only the most recent career entry is displayed). Your interests, collaborations, and association memberships are also not shared.
To see an example of a public professional profile, visit vetsurgeon.org, make sure you are logged out, and then see: www.vetsurgeon.org/members/alasdair.
Log back into the site, visit that same link, and you'll see that further career details, interests, membership etc are visible to members only.
If you have any questions about VetSurgeon Professional Profiles, you can ask them here: https://www.vetsurgeon.org/001/nonclinical/f/life-in-practice-discussions/30187/your-new-online-professional-profile/235777
The Veterinary Hospital and Surgery acquired the Magdalen Arms in late 2014 and started work on the conversion of the listed building in March 2015, with particular care needed to preserve original features including its Dutch gables and the falcon logo of local brewery Lacon’s, which is incorporated into the brick work.
The new hospital was officially opened at the end of February, with the Mayor of Great Yarmouth, Malcolm Bird, and local 2012 Paralympic gold medallist Jessica-Jane Applegate unveiling the plaque. More than 1,000 local people came to have a look round, many bringing their canine friends.
Clinical Director Elissa Norman said: "In recent years we had outgrown our original surgery and it started to become difficult to offer the level of service we wanted to within the space we had.
"We knew that the Magdalen Arms, in addition to being a well-known local landmark, offered all the space we needed, a central location and plenty of parking. The structure of the building made the conversion quite complex but the final result is beyond our expectations and we can’t wait to see the reaction of our clients when they bring their pets to us for the first time."
"We now have staff on site with patients 24 hours a day, 365 days of the year, plenty of parking and we can offer full access for disabled clients all of which were a priority for us. The reception area is spacious and inviting, the consult rooms are well equipped and the new cat ward will create a less stressful environment for our feline patients.
"Watching this much-loved building take shape as a brand-new hospital with all the facilities we need for our patients, their owners and our staff has been special and I’m looking forward to helping it take on a different role within the community. While the building work is now finished, we have lots of plans to develop the service we offer further over the next few months."
"We are grateful to the Mayor Malcolm Bird and to Jessica-Jane for helping us celebrate the opening of the hospital and it was great to welcome so many local people and show them around as they have been so supportive during the conversion. It is clear that the building holds a strong place in many of their memories but that they are as excited as we are to see the amazing transformation that has taken place. We look forward to serving them and caring for their pets in the years ahead."
Rabbit Viral Haemorrhagic Disease variant (RVHD2) is a variation of the already recognised Rabbit Viral Haemorrhagic Disease (RVHD1). Vaccines for the original strain of RVHD do not appear to offer long term protection against RVHD2, however vaccines for this new strain are now available in the UK and can be purchased through three UK wholesalers (NVS, Centaur and Henry Schein Animal Health) or direct from the suppliers in Europe. There have been supply issues with this vaccination, however these are hoping to be remedied soon.
RVHD2 is more variable in its rate of disease progression than RVHD1, with presentation ranging from sudden death (with or without bleeding from the orifices), to a longer disease course of three to nine days, increasing the risk of unwell rabbits being brought into practices and in turn increasing the risk of transmission to other pet rabbits. Until vaccination becomes more routine, biosecurity in practices is key to prevent the disease from spreading.
Sean Wensley, BVA President, said: "Although the risk of a rabbit contracting RVHD2 appears highest in situations where rabbits are kept in large groups with regular new additions, such as at breeders or rescue centres, we encourage all owners to speak to their vet about vaccinating their rabbits against RVHD2.
"Veterinary advice from The Rabbit Welfare Association and Fund (RWAF) has stated that the spread of RVHD2 may be facilitated by its apparent slower disease progression compared to RVHD1, and research suggests that we can expect to see RVHD2 starting to predominate in the UK’s wild rabbits over RVHD1 in the next five years or so."
John Chitty, BSAVA Vice President, said: "BSAVA would encourage practices to talk to rabbit owning clients about RVHD2 vaccines, and where there is deemed sufficient risk recommend the vaccine along with the essential vaccination against Myxomatosis – and it should be noted that this must not be done within two weeks of vaccination against RVHD2."
BVZS President and veterinary pathologist Mark Stidworthy said: "It is clear from post mortem examinations and PCR testing over the last 18 months that RVHD2 is now geographically widespread in the UK and all rabbits should be considered at risk from this potentially devastating disease."
Due to recent media coverage of RVHD2, vets may be contacted by concerned owners seeking advice on how to prevent their rabbits contracting this disease - further to vaccinating, vets should recommend rabbits are kept separate from any other rabbits they do not usually interact with; are prevented from having contact with wild rabbits and do not attend any rabbit shows unless already vaccinated.
For a detailed Q&A on RVHD2 from Richard Saunders MRCVS, veterinary advisor to the RWAF, including information on sourcing effective vaccines, visit www.rabbitwelfare.co.uk and click RVHD2 - Filavac Vaccine – FAQs on the home page.
Photo: Larry D. Moore CC BY-SA 3.0.
The Waltham Centre for Pet Nutrition has announced new research - published in BMC Vet Research1 - which examined the progression of periodontal disease in miniature schnauzers and found that without effective and frequent oral care, dental disease developed rapidly and advanced even more quickly with age.
Over the course of 60 weeks, full mouth examinations were conducted on 52 miniature schnauzers ranging in age between 1.3 and 6.9 years. Prior to the study, each dog had a regular oral care routine that included tooth brushing. This was suspended a week before the initial dental assessment. Of the 2,155 teeth examined, all entered the study with some level of gingivitis, while only 23 teeth entered with periodontitis.
Every 6 weeks, levels of gingivitis and periodontitis were assessed around the whole surface of each individual tooth by measuring periodontal probing depth, gingival recession and furcation exposure. Teeth were assessed for the level of gingivitis (scored between 0 and 4) and periodontitis (PD1 - up to 25% attachment loss and PD2 - between 25 to 50% attachment loss). Teeth from only one dog in the study did not progress to periodontitis.
Researchers found that, without regular oral care, the majority of dogs developed the early stages of periodontal disease within six months and dogs above the age of four developed periodontal disease even faster. The degree to which periodontal disease progressed varied based on the type of tooth and location on the tooth.
Furthermore, the study showed that periodontitis developed regardless of the visible signs of gingivitis, which had previously been believed to reliably precede it. Therefore while a visual inspection may be sufficient to detect a disease like gingivitis, it is not useful in detecting the onset of periodontitis and may not reveal the areas at greatest risk for dental disease.
Dr Stephen Harris, leader of the oral care team at WALTHAM, part of Mars Petcare said: "We all want to do the very best for our pets' health, and the study showed us that there's more than meets the eye when it comes to small dogs' oral health.
"Some pet owners "lift-the-lip" and look at a dog's gums to get a sense of its oral health, but this research shows they could be missing important early signs of dental disease. The findings should encourage all dog owners to establish an oral care routine that consists of regular tooth brushing supplemented with dental chews and veterinary checks. It's important for all dogs, but we know that small dogs like miniature schnauzers are at an even higher risk of developing severe dental problems."
Reference:
Intervet/Schering-Plough Animal Health has announced the replacement of its Bovilis® IBR with Bovilis® IBR Marker Live vaccine, a move that brings the UK into line with the rest of Europe where marker vaccines are favoured.
Many EU member states, including Scandinavia and Austria are now declared IBR-free, and others (Germany and Hungary) operate national eradication programmes. Using a marker vaccine will help farmers wishing to export animals, or semen, or those working towards an eradication programme in their herds.
Recent bulk milk and blood screening via Intervet/Schering-Plough's complimentary BeefCheck and DairyCheck has revealed that 72% of herds tested were positive for IBR exposure. Given the latent nature of infection, and the rumbling losses associated with subclinical disease, it should come as no surprise that farmers are increasingly interested in controlling IBR. Studies have shown that IBR infection can result in a milk yield reduction of 173 litres per infected animal, or over £400 a year, for a 100-cow herd.
According to Intervet/Schering-Plough, Bovilis IBR Marker Live is Europe's leading IBR vaccine. It can be given intra-muscularly or intra-nasally to calves as young as two weeks old, as well as pregnant dams. It is also licensed to be given together with the pneumonia vaccine Bovilis® Bovipast RSP. The primary course involves one dose in cattle over three months of age, with immunity in just four days from the intra-nasal method, and 14 days from injection. Stock need re-vaccination every six months.
The vaccine reduces the amount of virus excreted into the environment, so minimising the risk to stressed cattle which may have been brought into the herd, and be latently infected. It also makes it an excellent choice for producers with breeding bulls, which should not be vaccinated. Bulls have to be kept naïve, however, the marker vaccine can be used on females in the herd to minimise virus circulation. This way the threat is minimised, and bulls can be kept infection free.
Stephen has been an elected member of RCVS Council since 2012, having previously been an appointed member of Council representing the Royal Veterinary College between 2001 and 2009.
In 2016 he was re-elected to Council to serve a further four-year term and currently chairs the Legislation Working Party.
Stephen graduated from Cambridge in 1980 and subsequently spent time as a large animal practitioner. After undertaking further training in equine surgery and diagnostic imaging at the University of Liverpool, he studied for a PhD at the Royal Veterinary College (RVC) before returning to Liverpool as a Lecturer in Equine Orthopaedics.
He went back to the RVC in 1993 to concentrate on equine clinical services and, in 1997, became Head of the Farm Animal and Equine Clinical Department. He was appointed the RVC’s Vice-Principal for Teaching from 2000 to 2013, Deputy Principal from 2013 to 2017 and currently holds the post of Senior Vice-Principal.
Addressing the need for a learning culture in his speech Stephen said: "Veterinary graduates have never had greater knowledge and technical skills than those graduating this year. But this can make their job so much harder when the certainty of scientific knowledge is confronted with the uncertainties of the sick animal, and the increasing number of possibilities for treatment have to be weighted alongside ethical and economic considerations.
"Of his age, but also prophetic of our age, the philosopher Bertrand Russell commented that 'habits of thought cannot change as quickly as techniques with the result that as skill increases, wisdom fails'.
"So it is important that our young professionals are well-prepared in terms of professional, non-technical skills to cope with the sheer variety of challenges that they encounter, and we, as a profession, within our professional model, provide a nurturing learning culture rather than the blame and cover-up culture that the current emphasis on external regulation fosters, so pervasively and distressingly."
Stephen added that his other priorities would be working with the British Veterinary Association and other stakeholders to uphold the College’s first Brexit principle that 'vital veterinary work continues to get done', a project on graduate outcomes, which flows from the Vet Futures project, and the Legislation Working Party.
The Targets Task Force comprises a leading veterinary surgeon and farmer from each of the beef, dairy, egg, fish, gamebird, pig, poultry meat and sheep sectors, who have been consulting with key organisations in their respective industries. The group also includes observers from regulators Food Standards Agency and Veterinary Medicines Directorate (VMD).
While the targets each sector has set vary according to the availability of data and scope in their sector, the targets as a whole have been described as 'positive and proactive' by the VMD.
The headline targets for the eight sectors include a reduction in use of antibiotics in pigs by over 60% between 2015 and 2020, with minimal use of highest priority Critically Important Antibiotics (CIAs). RUMA reports that good progress has already been made in this sector, with usage falling by around 35% between 2015 and 2016.
Targets Task Force member and president of the Pig Veterinary Society Mark White said: "It's encouraging to see the response in the sector to the challenge laid down, which bodes well for achieving our ambitious 2020 goal. It is evident that the sector – steered mainly by the members of the Pig Veterinary Society, AHDB Pork and the National Pig Association – has the will and the capability to fully engage with the issue."
Next steps, he said, were to focus on eliminating routine preventative treatment where it is still happening, mainly due to lack of resource or expertise. "We can also work to improve water delivery systems so that more targeted treatment in the water can be used instead of in-feed medication."
The dairy cattle sector has committed to a 20% reduction by 2020, with a particular focus on halving use of the highest priority CIAs. The work to achieve this will be led by a newly-created Dairy Antimicrobial Stewardship Group (DASG) which includes all key organisations in the sector.
Some of the strategies to achieve these goals in dairy farming include reducing the use of antibiotic dry cow therapy and injectable products, and cutting back on group treatments such as antibiotic footbaths for lameness which remain largely unproven, instead using topical and targeted treatments.
Di Wastenage, dairy farmer from Devon, Task Force member and chair of the DASG, said the sector needed to be ambitious about what it could achieve. “While use is lower than in some sectors, there are clear areas to tackle where use can be habitual, or common disease problems go unchallenged.
"For example, eliminating BVD and Persistently Infected animals from the herd is one of the obvious places to start, as well as talking to your vet to calculate the usage levels you have at the moment. Calf rearing can produce a 'hot spot' of treatment, as can digital dermatitis. Everyone has the potential to use antibiotics more responsibly somewhere."
The gamebird sector, having undergone a comprehensive awareness-raising initiative among game rearers in 2017 to cut back on reducing the need for medicines, aims to reduce use by a quarter this year, with a further 25% reduction between 2018 and 2020.
Three sectors – poultry meat, laying hen and fish – are either already low users of medicines or have made significant reductions over the past five years. These sectors will be focusing on maintaining use at the minimal level needed to ensure good health and welfare among their livestock, while tackling emerging challenges should they arise.
The poultry meat sector, previously described as a 'pathfinder' for the rest of the farming industry, has already reduced use by 71% between 2012, when its stewardship scheme was introduced, and 2016.
In doing this, the poultry meat sector has also ceased all preventative treatment and use of the highest priority CIAs. It will now maintain current levels in chickens and look for further reductions in turkeys. This sector will use clinical governance to ensure CIA antibiotics are only prescribed when absolutely needed and with sign off from veterinary specialists and management.
The laying hen and fish sectors have similarly committed to continuing low use, with the laying hen sector eliminating all use of highest priority CIAs in the past two years. The development of a vaccine in the salmon sector several years ago successfully controlled one of its most challenging bacterial diseases, so the focus has turned to the health of the ‘cleaner fish’ used to provide natural control of sea lice.
The trout farming sector, with its greater number of small producers, is concentrating on reducing the need for antibiotics and improving data capture.
The beef and sheep sectors are already low users of antibiotics, but have acknowledged they each need better data, and will also commit to addressing 'hotspots' of use. Both have committed to a 10% reduction in antibiotic use by 2020, subject to securing better data.
For the beef sector, reduction in use centres around calves and youngstock, particularly in the areas of respiratory disease. There is also an emphasis on calves from dairy herds, where mixing animals from different sources can create a peak in disease pressure similar to children going to school for the first time.
In sheep, the focus areas are to reduce routine preventative antibiotic usage against abortion (miscarriage), lameness and neonatal lamb diseases such as watery mouth and joint ill.
With initiatives proving that routine preventative use is largely avoidable through a combination of vaccination, good hygiene, quality nutrition and careful shepherding, Dr Fiona Lovatt of the Targets Task Force is optimistic about the opportunities to reduce overall use.
"In the sheep sector, we’re not high users of antibiotics. But we want to ensure that any use is totally targeted so we are challenging all inappropriate or routine preventative use.
"Convincing farmers to change practices is tricky, and none of us want to see an increase in levels of disease, but those who have had the courage to work with their vets to change what they do are now seeing what is possible. The answer is to take a holistic approach and work closely with a keen sheep vet."
Gwyn Jones, chair of both RUMA and the Targets Task Force, said he has been overwhelmed by the positivity of the group and its willingness to be ambitious. "The members have worked very hard and have shown incredible leadership and persistence. They have also provided unprecedented support and inspiration to each other.
"I am delighted they have agreed that the group should continue to meet twice-yearly to review progress and discuss issues."
The full report with all targets for each sector can be downloaded from the RUMA website www.ruma.org.uk.
The event offers over 80 hours of CPD across seven streams – with everything from hypotension and sepsis to breaking bad news to clients – as well as world-renowned speakers and networking opportunities.
Søren Boysen from the University of Calgary in Canada and Sophie Adamantos from Paragon Referrals in Wakefield, are among several high-profile speakers at this year’s Congress.
Chief Executive for GB Snowsport, Victoria Gosling OBE, will open Congress as keynote speaker where she’ll focus on perseverance, resilience and teamwork.
Also speaking are Prof. John Williams, Richard Casey, executive director at the World Small Animal Veterinary Association and VDS trainer Elly Russell.
Arlene Connor, an RVN and head of clinical operations at Vets Now and IVC Evidensia has planned the programme alongside national ECC lead Dan Lewis (pictured right).
She said: “We’re so excited to be returning to the Royal Armouries for our 19th Vets Now ECC Congress – around a theme which celebrates us all being together again.
"The past two years have been a challenge for all of us in the veterinary professions and we hope to mitigate that with a return to face-to-face learning and networking, as well as the chance to have some fun.
"Events like this can be hugely inspirational — for the organisers as well as the attendees — and we truly can’t wait to welcome everyone through the doors like old times.”
Dan added: “There’s a brilliant line-up of live speakers, workshops, a packed exhibition hall and more opportunities than ever for delegates to meet old friends and make new ones, as well as to learn from some of the world’s leading veterinary experts discussing emergency and critical care.
“Our programme again this year has been carefully tailored to provide an inclusive learning experience for vets and vet nurses no matter what stage they’re at in their career, from students through to specialists.
Tickets range in price from £45 + VAT for exhibition-only tickets, up to £470 + VAT for a vet to attend for 2 days plus the Gala dinner.
To book your ticket, go to www.vets-now.com/congress2022
Bayer Animal Health, makers of Profender, has launched a campaign to reignite the age-long debate, 'Cats vs Dogs', to highlight the importance of protecting cats against intestinal worms.
Aiming to spark discussion between pet owners and vets, the campaign emphasises key differences between cats and dogs, including the challenges they present when it comes to worming control, such as cats' independent nature.
Previous research by Bayer Animal Health found that 42% of cat owners worry their pet does not swallow worming tablets, 38% are concerned that it will spit it out and 21 per cent say their cat runs away. This leaves potentially more than 750,000 cats unprotected from the parasite.
Launching in September, the campaign microsite http://www.catsvdogs.co.uk/, invites the public to vote for who they think rules, while uniting and educating owners over their common foe: intestinal worms. Voting closes at the end of November, with a tribute video to the winning species as voted for by the nation.
Alongside the microsite, a nationwide survey of pet owners is being conducted in partnership with Your Cat and Your Dog magazine to uncover pet owner perceptions of cats vs dogs, including parasite protection attitudes.
Campaign materials will also be supplied to veterinary practices, including an educational poster about worming control and applying spot-ons. For further information and campaign materials please get in touch with your local Bayer Animal Health Territory Manager.
For further information about Profender, or parasite control in companion animals, visit: http://www.itsajungle.co.uk/.
Vetoquinol has announced that the vouchers it provides as part of the Epiphen practice support package for monitoring and management of serum levels of phenobarbital will now be provided directly from the veterinary wholesaler and sent with each order.
One or two vouchers are provided with the 30ml and 60ml packs respectively. The vouchers come complete with a pre-paid envelope in which to send samples directly to the laboratory. Each test is valued at £19.80
For further information, contact your local Vetoquinol Territory Manager.